搜尋結果
Today's Refinance Rates: June 13, 2024—Rates Dip
Forbes· 4 小時前The rate on a 30-year fixed refinance tumbled today. The average rate on a 30-year fixed ...
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
CNBC· 3 日前Eli Lilly & Co.'s shares climbed in early US trading after its experimental drug for ...
Stock handouts might help save the US ruling class
Reuters· 4 小時前The American dream now runs through the stock market. Although politicians are struggling to ...
Alzheimer’s Disease Drug Donanemab Gets Unanimous Backing From FDA Expert Panel
Forbes· 2 日前The panel concluded that the therapeutic is effective in treating the memory-robbing condition ...
FDA Panel Unanimously Recommends Eli Lilly’s Alzheimer’s Drug
Forbes· 3 日前All of the panel’s 11 members endorsed donanemab—which data from a clinical trial suggests can ...
Patent decision offers new look at weighing of factors for discretionary denial by PTAB
Reuters· 20 小時前A current case to watch at the Patent Trial and Appeal Board (PTAB) is Vivendum Product Solutions, Inc. v. Rotolight Ltd ...
Eli Lilly’s Alzheimer’s Drug Donanemab Is Being Considered For FDA Approval—Here’s What To Know
Forbes· 3 日前The Peripheral and Central Nervous System Drugs Advisory Committee will meet on Monday to ...
A successful Alzheimer's drug will help Eli Lilly join the $1 trillion club
CNBC· 2 日前Eli Lilly became the most valuable health-care company in the world on the back of its ...
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its ...
CNBC· 2 日前CNBC's Jim Cramer on Tuesday explained why he continues to be bullish about pharmaceutical ...
Analyzing Vitalik Buterin And Gavin Wood’s EthPrague Fireside Chat
Forbes· 4 日前Ten years since Ethereum’s co-founders holed up in Switzerland to launch the OG smart contract ...